Europe
Nascum®-Plus works as a protective shield on the nasal mucosa where air pollutants trigger an allergic reaction
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Ingenza has announced that its collaboration with Syngenta for work on efficient technologies to support the development of crop protection products has been extended.
Recipharm AB (publ) announces that Tobias Hägglöv takes office as new Chief Financial Officer, effective today.
Healx today announced the appointment of Kate Hilyard PhD as Chief Operating Officer (COO).
Exscientia is pleased to announce the appointment of Mr Georgy Egorov as Chief Financial Officer (CFO) effective immediately.
Rewind Therapeutics announces the appointment of Ian J. Reynolds as its Chief Executive Officer (CEO).
Feedback plc (AIM: FDBK, “Feedback” or the “Company”), the specialist medical imaging technology company, announces a trading update for the year ended 31 May 2018 and the period to 30 September 2018.
KOL event to be held ahead of expected data release with elafibranor in PBC by end of 2018 (Phase 2) and in NASH end of 2019 (Phase 3)
Clinigen Group plc today announces that it has completed the acquisition of CSM Parent, Inc. (‘CSM’), which was announced on 27 September 2018 (the “Acquisition”).
PRESS RELEASES